Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres-Reference-Cited by-同舟云学术

Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres

Published:2022-06-15 Issue:5 Volume:9 Page:2873-2885
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Wissmüller Max¹²,Xanthouli Panagiota³⁴,Benjamin Nicola³⁴,Grünig Ekkehard³⁴,Richter Manuel J.⁴⁵,Gall Henning⁴⁵,Ghofrani Hossein Ardeschir⁴⁵,Herkenrath Simon⁶⁷,Skowasch Dirk⁸,Pizarro Carmen⁸,Halank Michael⁹,Hohmann Christopher¹²,Hellmich Martin¹⁰,Gerhardt Felix¹²,Rosenkranz Stephan¹²¹¹^ORCID

Affiliation:

1. Klinik III für Innere Medizin Herzzentrum der Universität zu Köln Kerpener Str. 62 Cologne 50935 Germany

2. Cologne Cardiovascular Research Center (CCRC) Universität zu Köln Cologne Germany

3. Zentrum für pulmonale Hypertonie, Thoraxklinik Universitätsklinikum Heidelberg und Translational Lung Research Centre Heidelberg Germany

4. Deutsches Zentrum für Lungenforschung (DZL) Giessen Germany

5. Abt. Pneumologie, Medizinische Klink II, Universitätsklinikum Gießen und Marburg Universities of Giessen and Marburg Lung Center (UGMLC) Giessen Germany

6. Institute for Pneumology University of Cologne Solingen Germany

7. Bethanien Hospital, Clinic of Pneumology and Allergology Center for Sleep Medicine and Respiratory Care Solingen Germany

8. Medizinische Klinik II Universitätsklinikum Bonn Bonn Germany

9. Medizinische Klinik I, Universitätsklinik Carl Gustav Carus TU Dresden Dresden Germany

10. Institut für Medizinische Statistik, Informatik und Epidemiologie (IMSIE) Universität zu Köln Cologne Germany

11. Center for Molecular Medicine Cologne (CMMC) Universität zu Köln Cologne Germany

Funder

Actelion Pharmaceuticals

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13804

Reference33 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

3. Selexipag for the Treatment of Pulmonary Arterial Hypertension

4. Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

5. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil;JHLT Open;2024-11

2. The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis;The Journal of Heart and Lung Transplantation;2024-09

3. Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities;European Journal of Heart Failure;2024-07-05

4. Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities;ERJ Open Research;2023-12-21

5. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis;Advances in Therapy;2023-09-20